Inovio Pharmaceuticals
INO
#9750
Rank
โ‚ฌ76.42 M
Marketcap
0,93ย โ‚ฌ
Share price
-3.64%
Change (1 day)
-24.57%
Change (1 year)

Revenue for Inovio Pharmaceuticals (INO)

Revenue in 2026 (TTM): N/A

In 2025 the company made a revenue of โ‚ฌ0.05 Million a decrease over the revenue in the year 2024 that were of โ‚ฌ0.2 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Inovio Pharmaceuticals from 1999 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) N/A-100%
2025 โ‚ฌ0.05 M-73.42%
2024 โ‚ฌ0.2 M-72.2%
2023 โ‚ฌ0.75 M-92.13%
2022 โ‚ฌ9.56 M510.49%
2021 โ‚ฌ1.56 M-73.99%
2020 โ‚ฌ6.02 M64.15%
2019 โ‚ฌ3.67 M-86.22%
2018 โ‚ฌ26.64 M-24.28%
2017 โ‚ฌ35.18 M4.65%
2016 โ‚ฌ33.62 M-9.38%
2015 โ‚ฌ37.1 M331.58%
2014 โ‚ฌ8.59 M-11.83%
2013 โ‚ฌ9.75 M213.2%
2012 โ‚ฌ3.11 M-58.72%
2011 โ‚ฌ7.54 M63.27%
2010 โ‚ฌ4.61 M-27.43%
2009 โ‚ฌ6.36 M324.25%
2008 โ‚ฌ1.5 M-54.43%
2007 โ‚ฌ3.29 M25.27%
2006 โ‚ฌ2.62 M-43.05%
2005 โ‚ฌ4.61 M436.43%
2004 โ‚ฌ0.86 M1245.12%
2003 โ‚ฌ0.06 M-64.72%
2002 โ‚ฌ0.18 M
2000 โ‚ฌ5.9 M-32.44%
1999 โ‚ฌ8.74 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ84.44 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ49.57 BN/A๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ55.48 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ26.05 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ57.63 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ38.70 BN/A๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
โ‚ฌ0.55 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
โ‚ฌ0.54 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA